XOMA Royalty (XOMA) Debt Ratio (2010 - 2026)
XOMA Royalty's (XOMA) quarterly Debt Ratio came in at 0.38 in Q1 2026, down 29.18% year-on-year from 0.53 in Q1 2025, and down 5.34% quarter-over-quarter from 0.4 in Q4 2025.
XOMA Royalty (XOMA) Debt Ratio (2010 - 2026) Analysis & Trends
XOMA Royalty has disclosed Debt Ratio across 16 years of filings, most recently posting 0.38 for Q1 2026.
- Debt Ratio for Q1 2026 came in at 0.38, down 29.18% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.38 (down 29.18% YoY), and the FY2025 annual result was 0.4, down 25.23% from the prior year.
- Debt Ratio came in at 0.38 for Q1 2026 at XOMA Royalty, down from 0.4 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 0.55 in Q1 2024 to a low of 0.38 in Q1 2026.
- The 4-year median for Debt Ratio is 0.52 (2024), against an average of 0.49.
- Across the five-year window, Debt Ratio advanced 2.63% in 2025 and fell 29.18% in 2026, its largest moves.
- XOMA Royalty's Debt Ratio stood at 0.53 in 2023, then climbed by 0.94% to 0.53 in 2024, then retreated by 25.23% to 0.4 in 2025, then decreased by 5.34% to 0.38 in 2026.
- The last three Debt Ratio figures came in at 0.38 (Q1 2026), 0.4 (Q4 2025), and 0.41 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 0.18 |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | XOMA Royalty | 5.52 Mn | -60.56 Mn | - | 0.38 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.38 |
| Dec 31, 2025 | 0.40 |
| Sep 30, 2025 | 0.41 |
| Jun 30, 2025 | 0.51 |
| Mar 31, 2025 | 0.53 |
| Dec 31, 2024 | 0.53 |
| Sep 30, 2024 | 0.53 |
| Jun 30, 2024 | 0.50 |
| Mar 31, 2024 | 0.55 |
| Dec 31, 2023 | 0.53 |
| Mar 31, 2021 | 0.16 |
| Dec 31, 2020 | 0.17 |
| Sep 30, 2020 | 0.35 |
| Jun 30, 2020 | 0.35 |
| Mar 31, 2020 | 0.34 |
| Dec 31, 2019 | 0.34 |
| Sep 30, 2019 | 0.38 |
| Jun 30, 2019 | 0.33 |
| Mar 31, 2019 | 0.30 |
| Dec 31, 2018 | 0.35 |